Anthropic Prices the Largest IPO Ever at $83 a Share, Raising $81 Billion
980 million shares, priced above a $70-to-$78 range, put the maker of Claude on Nasdaq today as ANT at about $1.5 trillion.

Anthropic set the price of its first public shares at $83 on Wednesday evening, above the top of the $70-to-$78 range it showed investors eight days earlier. At 980 million shares, the sale comes to about $81 billion, the most any company has ever raised in an IPO. Trading opens today on Nasdaq under the ticker ANT, and for the first time anyone with a brokerage account can own a piece of the company behind Claude.
155 Million Extra Shares, Still Not Enough
When Anthropic opened its roadshow on November 10, it offered 825 million shares at $70 to $78 each. By pricing night the offer had grown to 980 million shares, and every one of the extra 155 million came from the company itself. Anthropic sells 956,351,354 of them; a group of existing stockholders sells the remaining 23,648,646, and that money goes to them, not to the company.
The demand explains the move. Bloomberg reported during the roadshow that orders reached about six times the shares on offer. Goldman Sachs and Morgan Stanley, which run the deal, also hold a 30-day option to buy up to 147 million more shares if trading is strong.
“The pricing shows strong demand among investors.”— Dan Ives, Yorkville Ives & Co.
So how big is $81 billion, measured against everything Wall Street has sold before?
$6 Billion Past SpaceX's June Record
Five months ago SpaceX set the bar with an IPO of about $75 billion. Anthropic clears it by roughly $6 billion, according to the Associated Press, at a valuation of about $1.5 trillion. Last June, in its final private round, investors valued the company at $965 billion.
Spread across the planet, that is about $10 for every person alive. Most of it lands in Anthropic's own account, and the company has already said where a lot of it is going: its filings list commitments of about $900 billion for computing power and infrastructure in the coming years, $70 billion of it in the next 12 months.
That spending is the honest open question for new shareholders. Anthropic is not yet profitable under standard accounting rules and carries $6.2 billion in debt. What the IPO buys it is time and chips, at a scale only a public company can raise. And the people buying in will find the company's control works differently from almost any other on Nasdaq.
A Trust That Can Name Most of the Board
Anthropic is a public benefit corporation, a legal form that lets a company weigh a stated mission alongside profit. Its filings add a second layer: a Long-Term Benefit Trust that can elect or remove a majority of the board of directors. Public shareholders get the upside of the business; the trust keeps a hand on who steers it.
That design drew pushback before the listing. New York City's comptroller asked the company in October to pause the IPO over its governance plans. Anthropic went ahead, and investors still asked for several times the stock on offer.
For Dario Amodei and his sister Daniela, who co-founded the company in 2021, the day turns five years of private funding rounds into a public price that anyone can check every second. For everyone else it opens something new: the frontier labs have been the most talked-about companies of the decade, and until today almost nobody could buy one.
From this morning, a share of the company that makes Claude costs whatever the market says, and anyone can ask.
What people are saying
“We’ve priced our IPO at $83 per share, with trading expected to begin on Nasdaq tomorrow. Legal disclaimer: A registration statement relating to the Class A common stock was declared effective by the Securities and Exchange Commission on November 18,”
Anthropic's Road to a Record IPO
The Brief
Stay curious
AI and technology: what changes and why it matters.
Your daily selection, in English or Spanish.
Free forever. Unsubscribe anytime.
More stories

The Specialty News





Conversation
Start the conversation